Keebeck Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.57M | Sell |
24,608
-548
| -2% | -$102K | 0.6% | 46 |
|
2025
Q1 | $5.27M | Buy |
25,156
+148
| +0.6% | +$31K | 0.78% | 34 |
|
2024
Q4 | $4.44M | Sell |
25,008
-141
| -0.6% | -$25.1K | 0.64% | 44 |
|
2024
Q3 | $4.97M | Sell |
25,149
-234
| -0.9% | -$46.2K | 0.72% | 40 |
|
2024
Q2 | $4.35M | Buy |
25,383
+8,711
| +52% | +$1.49M | 0.64% | 41 |
|
2024
Q1 | $3.04M | Buy |
16,672
+13,380
| +406% | +$2.44M | 0.45% | 63 |
|
2023
Q4 | $510K | Buy |
3,292
+77
| +2% | +$11.9K | 0.08% | 174 |
|
2023
Q3 | $479K | Buy |
3,215
+168
| +6% | +$25K | 0.08% | 177 |
|
2023
Q2 | $411K | Buy |
3,047
+35
| +1% | +$4.72K | 0.06% | 193 |
|
2023
Q1 | $480K | Sell |
3,012
-716
| -19% | -$114K | 0.08% | 165 |
|
2022
Q4 | $602K | Buy |
3,728
+22
| +0.6% | +$3.56K | 0.11% | 140 |
|
2022
Q3 | $497K | Buy |
3,706
+8
| +0.2% | +$1.07K | 0.1% | 150 |
|
2022
Q2 | $566K | Buy |
3,698
+7
| +0.2% | +$1.07K | 0.11% | 146 |
|
2022
Q1 | $598K | Buy |
3,691
+8
| +0.2% | +$1.3K | 0.1% | 150 |
|
2021
Q4 | $499K | Buy |
3,683
+312
| +9% | +$42.3K | 0.09% | 149 |
|
2021
Q3 | $364K | Buy |
3,371
+8
| +0.2% | +$864 | 0.07% | 160 |
|
2021
Q2 | $379K | Sell |
3,363
-16,896
| -83% | -$1.9M | 0.05% | 188 |
|
2021
Q1 | $2.19M | Sell |
20,259
-114
| -0.6% | -$12.3K | 0.34% | 59 |
|
2020
Q4 | $2.18M | Buy |
20,373
+11
| +0.1% | +$1.18K | 0.38% | 55 |
|
2020
Q3 | $1.78M | Buy |
20,362
+904
| +5% | +$79.2K | 0.37% | 54 |
|
2020
Q2 | $1.91M | Buy |
+19,458
| New | +$1.91M | 0.6% | 38 |
|
2020
Q1 | – | Sell |
-2,458
| Closed | -$217K | – | 140 |
|
2019
Q4 | $217K | Buy |
+2,458
| New | +$217K | 0.07% | 136 |
|